IL166343A0 - Igg fc/hiv-gp 120/c3d fusion protein - Google Patents
Igg fc/hiv-gp 120/c3d fusion proteinInfo
- Publication number
- IL166343A0 IL166343A0 IL16634305A IL16634305A IL166343A0 IL 166343 A0 IL166343 A0 IL 166343A0 IL 16634305 A IL16634305 A IL 16634305A IL 16634305 A IL16634305 A IL 16634305A IL 166343 A0 IL166343 A0 IL 166343A0
- Authority
- IL
- Israel
- Prior art keywords
- hiv
- igg
- fusion protein
- fusion
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39760502P | 2002-07-23 | 2002-07-23 | |
| PCT/US2003/022917 WO2004009785A2 (en) | 2002-07-23 | 2003-07-23 | IgG Fc/HIV-gp120/C3d FUSION PROTEIN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL166343A0 true IL166343A0 (en) | 2006-01-16 |
Family
ID=30771086
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16634305A IL166343A0 (en) | 2002-07-23 | 2005-01-17 | Igg fc/hiv-gp 120/c3d fusion protein |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20060014148A1 (de) |
| EP (2) | EP1523492A4 (de) |
| JP (2) | JP2006509496A (de) |
| KR (1) | KR20050036960A (de) |
| CN (1) | CN100366631C (de) |
| AU (1) | AU2003256671B2 (de) |
| BR (1) | BR0312808A (de) |
| CA (1) | CA2493706A1 (de) |
| IL (1) | IL166343A0 (de) |
| MX (1) | MXPA05000874A (de) |
| NZ (1) | NZ537345A (de) |
| WO (1) | WO2004009785A2 (de) |
| ZA (1) | ZA200410324B (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1635876A (zh) | 2000-02-04 | 2005-07-06 | 杜克大学 | 人免疫缺陷病毒疫苗 |
| EP1331942A4 (de) | 2000-09-22 | 2005-03-16 | Univ Duke | Immunogen mit ligandengebundenem hiv-hüllprotein |
| US7033593B2 (en) | 2000-09-22 | 2006-04-25 | Duke University | Immunogen comprising an HIV envelope protein, a ligand and H2 peptide |
| US7195768B2 (en) | 2001-11-07 | 2007-03-27 | Duke University | Polyvalent immunogen |
| US7172761B2 (en) | 2001-11-07 | 2007-02-06 | Duke University | Polyvalent immunogen |
| CA2466050A1 (en) | 2001-11-07 | 2003-05-15 | Duke University | Polyvalent immunogen |
| GB0614780D0 (en) * | 2006-07-25 | 2006-09-06 | Ucb Sa | Biological products |
| WO2009137632A2 (en) * | 2008-05-06 | 2009-11-12 | Government Of The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Hiv immunogen and method of making and using same |
| WO2010045613A1 (en) * | 2008-10-16 | 2010-04-22 | New York Blood Center | Immunoenhancer-linked oligomeric hiv vaccines |
| EP2485758A1 (de) * | 2009-10-09 | 2012-08-15 | New York Blood Center, Inc. | Immunstimulator-verbundene oligomere immunogene influenza-zusammensetzungen |
| WO2011126576A2 (en) * | 2010-04-09 | 2011-10-13 | Duke University | Genetic signatures in the envelope glycoprotein of hiv-1 |
| KR101384552B1 (ko) | 2010-05-24 | 2014-04-11 | 가부시키가이샤 포카코포레이션 | 제립 방법 및 제립 장치 |
| JP2014534807A (ja) * | 2011-09-23 | 2014-12-25 | ユニバーシティ オブ オスロUniversity of Oslo | クロスプレゼンテーションを行う樹状細胞を標的としたワクチボディ |
| EP2706356A1 (de) * | 2012-09-06 | 2014-03-12 | Laboratorios Del. Dr. Esteve, S.A. | Verfahren zur Identifizierung HIV-neutralisierender Antikörper |
| ES2768957T3 (es) * | 2015-09-24 | 2020-06-24 | Abvitro Llc | Composiciones de anticuerpos contra el VIH y métodos de uso |
| AU2018366480C1 (en) * | 2017-11-17 | 2024-02-01 | Grifols Diagnostic Solutions Inc. | Novel mammalian expressed human immunodeficiency virus envelope protein antigens |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5225538A (en) * | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| DK0699077T3 (da) * | 1993-05-07 | 2002-01-21 | Bio Merieux Inc | Immunogele HIV-komplekser |
| EP1331942A4 (de) | 2000-09-22 | 2005-03-16 | Univ Duke | Immunogen mit ligandengebundenem hiv-hüllprotein |
| CA2466050A1 (en) | 2001-11-07 | 2003-05-15 | Duke University | Polyvalent immunogen |
-
2003
- 2003-07-23 CN CNB038171961A patent/CN100366631C/zh not_active Expired - Fee Related
- 2003-07-23 BR BR0312808-3A patent/BR0312808A/pt not_active IP Right Cessation
- 2003-07-23 US US10/518,523 patent/US20060014148A1/en not_active Abandoned
- 2003-07-23 EP EP03765923A patent/EP1523492A4/de not_active Withdrawn
- 2003-07-23 WO PCT/US2003/022917 patent/WO2004009785A2/en not_active Ceased
- 2003-07-23 AU AU2003256671A patent/AU2003256671B2/en not_active Ceased
- 2003-07-23 CA CA002493706A patent/CA2493706A1/en not_active Abandoned
- 2003-07-23 EP EP10013160A patent/EP2374811A1/de not_active Withdrawn
- 2003-07-23 KR KR1020057001219A patent/KR20050036960A/ko not_active Withdrawn
- 2003-07-23 NZ NZ537345A patent/NZ537345A/en not_active IP Right Cessation
- 2003-07-23 JP JP2004523297A patent/JP2006509496A/ja not_active Withdrawn
- 2003-07-23 MX MXPA05000874A patent/MXPA05000874A/es unknown
-
2004
- 2004-12-22 ZA ZA200410324A patent/ZA200410324B/en unknown
-
2005
- 2005-01-17 IL IL16634305A patent/IL166343A0/xx unknown
-
2009
- 2009-10-02 JP JP2009230429A patent/JP2010057490A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CN100366631C (zh) | 2008-02-06 |
| JP2006509496A (ja) | 2006-03-23 |
| BR0312808A (pt) | 2005-04-19 |
| NZ537345A (en) | 2007-12-21 |
| US20060014148A1 (en) | 2006-01-19 |
| WO2004009785A2 (en) | 2004-01-29 |
| EP1523492A2 (de) | 2005-04-20 |
| MXPA05000874A (es) | 2005-03-23 |
| JP2010057490A (ja) | 2010-03-18 |
| WO2004009785A3 (en) | 2004-08-05 |
| KR20050036960A (ko) | 2005-04-20 |
| CA2493706A1 (en) | 2004-01-29 |
| AU2003256671A1 (en) | 2004-02-09 |
| EP2374811A1 (de) | 2011-10-12 |
| AU2003256671B2 (en) | 2008-10-16 |
| ZA200410324B (en) | 2006-07-26 |
| CN1668633A (zh) | 2005-09-14 |
| EP1523492A4 (de) | 2006-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL166751A0 (en) | Modified transferin-antibody fusion proteins | |
| AU2002364586A8 (en) | Albumin fusion proteins | |
| AU2002364587A8 (en) | Albumin fusion proteins | |
| IL202255A0 (en) | Binding domain-immunoglobulin fusion proteins | |
| AU2003239365A8 (en) | Recombinant glycosyltransferase fusion proteins | |
| EP1448588A4 (de) | Psma-antikörper und proteinmultimere | |
| AU2002307255A1 (en) | Vegf fusion proteins | |
| ZA200308589B (en) | Recombinant fusion proteins and the trimers thereof. | |
| AU2002332041A1 (en) | Albumin fusion proteins | |
| AU2003228364A8 (en) | Field-assisted fusion bonding | |
| AU2003253621A1 (en) | Modified "s" antibodies | |
| HUP0402496A3 (en) | Growth hormone fusion protein | |
| AU2002361390A1 (en) | Anti-cd7 immunotoxin as fusion protein | |
| EP1523492A4 (de) | Igg-fc/hiv-gp120/c3d-fusionsprotein | |
| GB9913437D0 (en) | Fusion proteins | |
| AU2002257088A1 (en) | Immunoglobulin superfamily proteins | |
| AU2002357891A8 (en) | Dtat fusion toxin | |
| EP1572092A3 (de) | Mk2 wechselwirkungs-proteine | |
| PL374439A1 (en) | Antibodies and uses thereof | |
| GB0200689D0 (en) | Fusion proteins | |
| AU2002231602A1 (en) | Rank ligand-binding polypeptides | |
| GB0213760D0 (en) | A fusion protein | |
| AU2002361963A1 (en) | Fusion proteins containing tlp peptides | |
| GB2370039B (en) | Producing protein arrays and fusion protein for use therein | |
| AU2003230516A1 (en) | Fusion polypeptide, use thereof and methods employing it |